SOCS3 and hepatocellular carcinoma: We found a close relation between SOCS3 methylation status and TACE treatment response, as well as survival of HCC patients, suggesting SOCS3 methylation status can be used as a marker to predict the TACE treatment response and prognosis of HCC patients.